In October 2018, Biomatrica was acquired by Exact Sciences (NASDAQ:EXAS) located in Wisconsin perhaps best known for it development with the Mayo Clinic of the far less invasive test for colon cancer, Cologuard. Biomatrica, Inc., is a biotechnology company organized around developing equipment for storing and preserving biological samples: providing solutions for stabilizing, processing, storing, shipping, and assaying biological samples at room temperature. The firm offers pre-analytics products for immediate stabilization, shipping, and short-term preservation of nucleic acids; stability products for long-term stabilization of nucleic acids; and assay enhancers for enhancing assay performance. The company also provides laboratory sample management software products, storage accessories, and custom products and solutions. Its products enable researchers in academia, pharmaceutical drug development, and molecular diagnostics to stabilize, ship, and store biological samples for long periods of time, Biomatrica® offers an innovative alternative to reliance on cold chain logistics. The firm has developed SampleMatrix® a proprietary core technology to stabilize and protect biological materials at room temperature without degradation. The SampleMatrix technology was designed by combining extremophile biology that enables long-term survival of organisms in extremely dry environments, with synthetic chemistry. By exploiting these unique characteristics, Biomatrica products enable researchers in academia, pharmaceutical drug development, and molecular diagnostics to stabilize, ship and store biological samples for long periods of time with complete and rapid sample recovery, and at very affordable costs. Specialties Novel core technology designed to prevent the degradation of complex samples, Reagents and assays during transport, Biological material storage and processing, Ambient Assay Solutions for Diagnostics
